gastroenterology

News

UEGW delegates hear of strides forward in IBD treatment

Trials of Lilly's Omvoh, Gilead's emvistegrast, Takeda's Entyvio, AbbVie's ABBV-466, and Sanofi/Teva's duvakitug are highlights of UEGW.

News

MSD's TL1A drug tulisokibart delivers in pivotal IBD trial

MSD's tulisokibart has become the first anti-TL1A antibody to help patients with ulcerative colitis achieve clinical remission in a phase 3 trial.

News

FDA fast-tracks Teva's coeliac disease treatment

Teva gets fast-track status from the FDA for a coeliac disease drug with a mechanism that has proved tough to crack.

News

Imec showcases ingestible sensor for gut studies

Imec will demonstrate an ingestible sensor device today that can monitor gut health and could be a valuable tool for research and clinical trials.

R&D

Obesity and the endoscopy space: Innovative, minimally invas...

According to the World Health Organization (WHO), in 2022, 2.5 billion adults aged 18 years and older were overweight, including over 890 million adults who were living with

News

EnteroBiotix cues up larger trial of microbiome IBS therapy

EnteroBiotix has reported phase 2a proof-of-concept data for its therapy for irritable bowel syndrome (IBS) based on gut microbiome species.

UEGW delegates hear of strides forward in IBD treatment

MSD's TL1A drug tulisokibart delivers in pivotal IBD trial

FDA fast-tracks Teva's coeliac disease treatment

Imec showcases ingestible sensor for gut studies

Obesity and the endoscopy space: Innovative, minimally invas...

EnteroBiotix cues up larger trial of microbiome IBS therapy

Astellas pays $285m for Audax cancer drug, and other deals

Discover a new era of healthcare panel engagement: Grounded ...

gastroenterology

Editor's Picks